ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Manager, Medical Science Liaison, UK at Revolution Medicines - ApplyBlast

Senior Manager, Medical Science Liaison, UK

Revolution Medicines

2 days ago

3.5 on Glassdoor

Remote

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Revolution Medicines is seeking a Senior Manager, Medical Science Liaison for the UK to execute field medical plans, engage in scientific exchange with healthcare professionals, and gather medical insights. This role serves as a key liaison between the company and healthcare providers, cultivating relationships with key opinion leaders and supporting clinical study engagement. The position requires collaboration with internal medical affairs and cross-functional teams to advance oncology research and medical education.

Responsibilities

Execute approved field medical plans and engage in peer-to-peer scientific exchange with healthcare professionals
Cultivate and strengthen professional relationships with key opinion leaders and academic centers of excellence
Collect and communicate medical insights to support clinical study site and investigator engagement

Skills

Qualifications

PhDMPharmMDMSc

About Revolution Medicines

revmed.com

Headquarters

Redwood City, California, United States

Company Size

201-500 employees

Founded

2014

View Profile

Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.